Will patients/consumers of Froedtert Health and ThedaCare be better off after the just announced merger of the two Wisconsin health systems?

There are three narratives about Protasiewicz and the election that deserve to be called out as wrongheaded.

Wisconsin did not have what could be safely described as a liberal majority 15 years ago and quite possibly ever — if you count the many years in which “liberal” and “conservative” were not terms commonly applied to Supreme Court justices and contenders.

Newsflash: It’s not just about the candidate.

The WOW counties delivered less wow for the Republican Party.

The lines changed for the suburban seat in the latest round of redistricting, making it an even more GOP-leaning. And Dan Knodl won by less than 2%.

Baldwin is an unabashed liberal who wins in a purple state. Hers is a formula Democrats should study to understand how to do this right.

America is irrefutably, overwhelmingly progressive in its total tax and transfer system. Wisconsin neither needs to nor can afford to be.

Led by young people, the resounding result of our spring election was, in large part, a referendum on Republican governance over the last decade. It’s time to listen to the will of the majority and make Wisconsin a place where people want to live, work, and play.

Eliminating literary art installation in preparation for Republican National Convention?

In Wisconsin,146,008 children are alone and unsupervised after school.

A blend of old and new can be found in Milwaukee’s “Food for Health” enterprise.

Baldwin’s announcement she’ll run again fits the political moment.

The concept of “personhood” has important implications in both legal and ethical realms.

Low-wage workers actually come out ahead by cutting back on their hours to stay eligible for benefits. Under the system that’s in place, the poor are damned if they do work and damned if they don’t.

Require all candidates to live in the district they are wanting to represent before they start circulating nomination papers.

The number of biolabs now performing research with dangerous pathogens—many in dense population areas—is skyrocketing.

The pause on mifepristone threatens the FDA’s authority over the approval process for medications in general and could have far-reaching consequences for patients’ access to other FDA-approved medications.